PAPER Civeira F, Martín C, Cenarro A
SEARCH RESULTS
330883 RESULTS
PAPER
Critical Alzheimer's disease legislation advances in Congress.
Alzheimers Dement. 2024 Apr;20(4):3141-3142. PubMed: 38643387PAPER Niccolai E, Pedone M, Martinelli I, Nannini G, Baldi S, Simonini C, Di Gloria L, Zucchi E, Ramazzotti M, Spezia PG, Maggi F, Quaranta G, Masucci L, Bartolucci G, Stingo FC, Mandrioli J, Amedei A
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules.
J Neurol. 2024 Apr 21; PubMed: 38644373PAPER Aiello EN, Solca F, Torre S, Colombo E, Maranzano A, De Lorenzo A, Patisso V, Treddenti M, Curti B, Morelli C, Doretti A, Verde F, Ferrucci R, Barbieri S, Ruggiero F, Priori A, Silani V, Ticozzi N, Poletti B
Longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in non-demented ALS patients.
Eur Neurol. 2024 Apr 20; PubMed: 38643758PAPER Zamboni G, Maramotti R, Salemme S, Tondelli M, Adani G, Vinceti G, Carbone C, Filippini T, Vinceti M, Pagnoni G, Chiari A
Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia.
J Neurol. 2024 Apr 21; PubMed: 38643445PAPER Tian X, Zhao Y, Zhu Y, Cui M
Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study.
Arch Gerontol Geriatr. 2024 Apr 20;124:105441. PubMed: 38643666PAPER Lemche E, Killick R, Mitchell J, Caton PW, Choudhary P, Howard JK
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
Neurobiol Dis. 2024 Apr 19;:106485. PubMed: 38643861PAPER Cai Z, Yang Z, Li H, Fang Y
Research progress of PROTACs for neurodegenerative diseases therapy.
Bioorg Chem. 2024 Apr 18;147:107386. PubMed: 38643565PAPER Sharma V, Chander Sharma P, Reang J, Yadav V, Kumar Tonk R, Majeed J, Sharma K
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach.
Bioorg Chem. 2024 Apr 17;147:107378. PubMed: 38643562Thomas Beach on Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
COMMENT Agree that it is no longer correct to assume that white matter rarefaction is equivalent to or completely accounted for by small vessel disease. Our comprehensive postmortem study suggests that neuofibrillary tangles are statistically a much greater predi
Thomas Beach on Skin Deep: Punch Biopsies Detect Synucleinopathies
COMMENT The publication of Gibbons et al., like most clinical biomarker studies, suffers first and foremost from the use of an inadequate gold standard. The clinical diagnoses of Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy are all
CSIRO Postdoctoral Fellowship in PET Neuroimaging for Alzheimer's Disease
JOB 2024-04-21 Employer CSIRO Principal Investigator Vincent Dore Contact For further information about the role and to apply, https://jobs.csiro.au/job-invite/95539/. Description CSIRO Early Research Career (CERC) Postdoctoral Fellowships provide opportunities to scien
PAPER
Repurposing a diabetes drug to treat Parkinson's disease.
Nat Med. 2024 Apr 20; PubMed: 38643318PAPER Koch NA, Voss P, Cisneros-Franco JM, Drouin-Picaro A, Tounkara F, Ducharme S, Guitton D, de Villers-Sidani É
Eye movement function captured via an electronic tablet informs on cognition and disease severity in Parkinson's disease.
Sci Rep. 2024 Apr 20;14(1):9082. PubMed: 38643273PAPER Stephens GS, Park J, Eagle A, You J, Silva-Pérez M, Fu CH, Choi S, Romain CP, Sugimoto C, Buffington SA, Zheng Y, Costa-Mattioli M, Liu Y, Robison AJ, Chin J
Persistent ∆FosB expression limits recurrent seizure activity and provides neuroprotection in the dentate gyrus of APP mice.
Prog Neurobiol. 2024 Apr 18;:102612. PubMed: 38642602Current Filters
- Date Range : All x